| scholarly article | Q13442814 |
| P2093 | author name string | David G Harrison | |
| Sergey I Dikalov | |||
| Hana A Itani | |||
| Rafal R Nazarewicz | |||
| William G McMaster | |||
| Anna E Dikalova | |||
| Alfiya T Bikineyeva | |||
| P2860 | cites work | Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial | Q24654699 |
| Inflammation, immunity, and hypertensive end-organ damage | Q26827525 | ||
| Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress | Q27015633 | ||
| Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death | Q28242641 | ||
| Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth | Q30457642 | ||
| Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 | ||
| Redox signaling, vascular function, and hypertension | Q33689229 | ||
| Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial | Q33764759 | ||
| Therapeutic targeting of mitochondrial superoxide in hypertension | Q33981734 | ||
| The kidney, hypertension, and obesity | Q34182175 | ||
| Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository | Q34239533 | ||
| DC isoketal-modified proteins activate T cells and promote hypertension. | Q34454645 | ||
| Is mPTP the gatekeeper for necrosis, apoptosis, or both? | Q34630758 | ||
| Mechanisms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ. | Q35141354 | ||
| Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation | Q35183974 | ||
| Mitochondria: are they the seat of senescence? | Q35668395 | ||
| Vascular inflammatory cells in hypertension | Q35939300 | ||
| Measurement of reactive oxygen species in cardiovascular studies | Q36012674 | ||
| Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
| Endothelial mechanotransduction, nitric oxide and vascular inflammation. | Q36440491 | ||
| Is hypertension an inflammatory process? | Q36490558 | ||
| Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility. | Q36636078 | ||
| Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension | Q36641593 | ||
| From mitochondria to disease: role of the renin-angiotensin system | Q36929305 | ||
| The neuromediator glutamate, through specific substrate interactions, enhances mitochondrial ATP production and reactive oxygen species generation in nonsynaptic brain mitochondria | Q37194236 | ||
| Nox2 as a potential target of mitochondrial superoxide and its role in endothelial oxidative stress | Q37234971 | ||
| Role of mitochondrial oxidative stress in hypertension | Q37342179 | ||
| Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension | Q37460353 | ||
| Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models. | Q37460376 | ||
| The mitochondrial permeability transition pore and cyclophilin D in cardioprotection | Q37835986 | ||
| Hypertension in kidney transplant recipients. | Q37850471 | ||
| Mitochondria: a pathogenic paradigm in hypertensive renal disease | Q38268844 | ||
| Redox characterization of human cyclophilin D: identification of a new mammalian mitochondrial redox sensor? | Q39802617 | ||
| Oxidative stress and hypertension | Q43090108 | ||
| American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors | Q43421277 | ||
| Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. | Q44049211 | ||
| Complement activation in angiotensin II-induced organ damage | Q46658434 | ||
| Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice | Q46757550 | ||
| Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction | Q46838383 | ||
| Hypertension and endothelial dysfunction: therapeutic approach. | Q51658124 | ||
| Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. | Q53573587 | ||
| A noninvasive computerized tail-cuff system for measuring blood pressure in mice | Q72210808 | ||
| Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress | Q79173099 | ||
| Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension | Q80552078 | ||
| ESR techniques for the detection of nitric oxide in vivo and in tissues | Q81487187 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1218-1227 | |
| P577 | publication date | 2016-04-11 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Mitochondrial Cyclophilin D in Vascular Oxidative Stress and Hypertension | |
| P478 | volume | 67 |
| Q64283963 | 1,2,3,4,6-Penta-O-galloyl-β-d-glucose modulates perivascular inflammation and prevents vascular dysfunction in angiotensin II-induced hypertension |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q49899669 | Blocking mitochondrial cyclophilin D ameliorates TSH-impaired defensive barrier of artery |
| Q47664376 | Cellular accumulation and antioxidant activity of acetoxymethoxycarbonyl pyrrolidine nitroxides |
| Q39389565 | Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis |
| Q90726251 | Comprehensive assessment of mitochondrial respiratory function in freshly isolated nephron segments |
| Q59812039 | Differential expression of MicroRNA let-7e and 296-5p in plasma of Egyptian patients with essential hypertension |
| Q42498639 | Elucidating Mitochondrial Electron Transport Chain Supercomplexes in the Heart During Ischemia-Reperfusion |
| Q41627358 | Enhanced Mitochondrial Transient Receptor Potential Channel, Canonical Type 3-Mediated Calcium Handling in the Vasculature From Hypertensive Rats |
| Q52685560 | Measurement of Reactive Oxygen Species (ROS) and Mitochondrial ROS in AMPK Knockout Mice Blood Vessels. |
| Q92020481 | Mitochondrial superoxide disrupts the metabolic and epigenetic landscape of CD4+ and CD8+ T-lymphocytes |
| Q39018896 | Oxidative Stress and Hypertensive Diseases |
| Q46184389 | Physiological Levels of Nitric Oxide Diminish Mitochondrial Superoxide. Potential Role of Mitochondrial Dinitrosyl Iron Complexes and Nitrosothiols |
| Q55260529 | Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway. |
| Q39342382 | Role of the Immune System in Hypertension |
| Q92511912 | T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of ·NO/cGMP Signaling |
| Q91276580 | Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles |
| Q41660449 | The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side |
Search more.